http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010279575-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2be1016a4aeae16e865165f38fbc7606 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-06 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate | 2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccc1809010902746f415d286141f55e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b279cc877b09152a2927dce482fd933f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9748a8b3251419bb9e07cd44a7d9fe24 |
publicationDate | 2016-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2010279575-B2 |
titleOfInvention | Swallowable capsule and method for stimulating incretin production within the intestinal tract |
abstract | Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract. The capsule can include two or more electrodes for providing electrical stimulation to L-cells, a power source for powering one or more components of the capsule, a sensor for sensing the location of the capsule in the intestinal tract; a controller and a waveform generator for generating the electrical signals emitted by the electrodes to stimulate the L-cells to secrete incretins such as GLP-1 to stimulate insulin production for glucose regulation of diabetic conditions. |
priorityDate | 2009-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 158.